Whittemore Tingley's most recent trade in Tenaya Therapeutics Inc was a trade of 1,837 Common Stock done at an average price of $1.3 . Disclosure was reported to the exchange on Aug. 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tenaya Therapeutics Inc | Whittemore Tingley | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.25 per share. | 18 Aug 2025 | 1,837 | 172,803 | - | 1.3 | 2,302 | Common Stock |
| Tenaya Therapeutics Inc | Whittemore Tingley | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.25 per share. | 18 Aug 2025 | 1,608 | 176,248 | - | 1.3 | 2,015 | Common Stock |
| Tenaya Therapeutics Inc | Whittemore Tingley | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.25 per share. | 18 Aug 2025 | 1,608 | 174,640 | - | 1.3 | 2,015 | Common Stock |
| Tenaya Therapeutics Inc | Whittemore Tingley | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.44 per share. | 16 May 2025 | 2,937 | 171,856 | - | 0.4 | 1,300 | Common Stock |
| Tenaya Therapeutics Inc | Whittemore Tingley | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.54 per share. | 10 Mar 2025 | 4,073 | 176,391 | - | 0.5 | 2,193 | Common Stock |
| Tenaya Therapeutics Inc | Whittemore Tingley | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.54 per share. | 10 Mar 2025 | 1,727 | 180,464 | - | 0.5 | 930 | Common Stock |
| Tenaya Therapeutics Inc | Whittemore Tingley | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.54 per share. | 10 Mar 2025 | 1,598 | 174,793 | - | 0.5 | 860 | Common Stock |
| Tenaya Therapeutics Inc | Whittemore Tingley | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 235,000 | 235,000 | - | - | Stock Option (Right to buy) | |
| Tenaya Therapeutics Inc | Whittemore Tingley | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jan 2025 | 215,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Tenaya Therapeutics Inc | Whittemore Tingley | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 215,000 | 215,000 | - | - | Stock Option (Right to Buy) | |
| Tenaya Therapeutics Inc | Whittemore Tingley | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jan 2025 | 205,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Tenaya Therapeutics Inc | Whittemore Tingley | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 205,000 | 205,000 | - | - | Stock Option (Right to Buy) | |
| Tenaya Therapeutics Inc | Whittemore Tingley | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jan 2025 | 141,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Tenaya Therapeutics Inc | Whittemore Tingley | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 141,000 | 141,000 | - | - | Stock Option (Right to Buy) | |
| Tenaya Therapeutics Inc | Whittemore Tingley | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jan 2025 | 69,982 | 0 | - | - | Stock Option (Right to Buy) | |
| Tenaya Therapeutics Inc | Whittemore Tingley | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 69,982 | 69,982 | - | - | Stock Option (Right to Buy) | |
| Tenaya Therapeutics Inc | Whittemore Tingley | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 40,000 | 147,106 | - | 0 | Common Stock | |
| Tenaya Therapeutics Inc | Whittemore Tingley | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 31,676 | 178,782 | - | 0 | Common Stock | |
| Tenaya Therapeutics Inc | Whittemore Tingley | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.89 per share. | 16 Aug 2024 | 5,803 | 108,731 | - | 2.9 | 16,797 | Common Stock |
| Tenaya Therapeutics Inc | Whittemore Tingley | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.89 per share. | 16 Aug 2024 | 1,625 | 107,106 | - | 2.9 | 4,704 | Common Stock |
| Tenaya Therapeutics Inc | Whittemore Tingley | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 215,000 | 215,000 | - | - | Stock Option (Right to buy) | |
| Tenaya Therapeutics Inc | Whittemore Tingley | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 35,000 | 108,534 | - | 0 | Common Stock | |
| Tenaya Therapeutics Inc | Whittemore Tingley | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 5.86 per share. | 16 Feb 2024 | 6,500 | 73,534 | - | 5.9 | 38,090 | Common Stock |
| Tenaya Therapeutics Inc | Whittemore Tingley | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 3.81 per share. | 16 Aug 2023 | 5,563 | 76,437 | - | 3.8 | 21,195 | Common Stock |
| Tenaya Therapeutics Inc | Whittemore Tingley | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 205,000 | 205,000 | - | - | Stock Option (Right to buy) | |
| Tenaya Therapeutics Inc | Whittemore Tingley | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 45,000 | 80,000 | - | 0 | Common Stock | |
| Tenaya Therapeutics Inc | Whittemore Tingley | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 35,000 | 35,000 | - | 0 | Common Stock | |
| Tenaya Therapeutics Inc | Whittemore Tingley | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 141,000 | 141,000 | - | - | Stock Option (Right to buy) |